News |

Study provides confidence in timeliness and sensitivity of AusVaxSafety

A new simulation study on Australia’s leading active vaccine safety surveillance system, AusVaxSafety, has been released that shows that the system is robust and would have detected a vaccine safety signal had it been operating in 2010 when there was an unprecedented number of febrile seizures in young children associated with one specific influenza vaccine brand, Fluvax (CSL Biotherapies). Fluvax was subsequently prohibited for use in children.

Read more on AusVaxSafety website. 



News & events

News |

More pharmacists will be able to vaccinate children under 5. Here’s what you need to know
News |

50 Years of Deadly: why NAIDOC Week 2026 matters for immunisation

News |

NCIRS visit to China strengthens collaboration on HPV vaccination
News |

Aboriginal and Torres Strait Islander Immunisation Leadership Committee meet to shape priorities for the year ahead
News |

Australia is battling its worst diphtheria outbreak in decades. But vaccines could curb it
News |

NCIRS study finds serious recurrent complications after TTS are rare, but persistent symptoms affecting physical and mental health are common
News |

Poliovirus detected in wastewater in Australia
News |

Understanding behavioural and social drivers of childhood vaccination in Timor Leste
News |

Before vaccines, diphtheria used to kill hundreds each year. Now it’s back in Australia
News |

Australian study identifies major mpox immunity gap, signals need to strengthen outbreak prevention measures
All news & events